Pfizer Recalls Lot of Neurontin
Pfizer Recalls Lot of Neurontin
Pfizer (New York, NY, www.pfizer.com) has voluntarily recalled one lot (40,000 bottles) of its epilepsy medication "Neurontin." According to the company, a manufacturing mechanical failure resulted in some bottles containing empty or partially filled capsules.
The recall affects only 100-mg capsules from lot #15224V, distributed during October and November 2004, only in the United States. The company said it is possible that patients taking Neurontin could experience seizures from a missed dose of the product, and patients should consult with their physician before discontinuing the drug.
Pfizer said the recall of the affected lot will not result in a shortage of Neurontin 100-mg capsules. Consumers are encouraged to contact Pfizer Medical Information at 800.438.1985 if they have any questions about the recall.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
